Compare Stocks: IBAC, QSI, QTRX, and CDXS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDXS Codexis	$1.32 -3.6%	$1.54	$0.96 ▼ $2.98	$144.55M	2.52	858,386 shs	464,301 shs
IBAC IB Acquisition	$11.26 -0.4%	$10.90	$10.19 ▼ $11.64	$56.59M	N/A	2,413 shs	3,249 shs
QSI Quantum-Si	$0.83 +6.3%	$0.77	$0.69 ▼ $3.10	$182.62M	3.25	1.42 million shs	2.57 million shs
QTRX Quanterix	$3.27 +2.8%	$3.08	$2.15 ▼ $8.77	$154.65M	1.04	870,156 shs	563,465 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDXS Codexis	0.00%	-2.94%	-20.48%	-44.77%	-46.77%
IBAC IB Acquisition	0.00%	-3.31%	+3.59%	+4.31%	+5.98%
QSI Quantum-Si	0.00%	+11.97%	+3.88%	-2.40%	-48.18%
QTRX Quanterix	0.00%	+6.51%	+23.86%	-24.31%	-38.30%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDXS Codexis	$1.32 -3.6%	$1.54	$0.96 ▼ $2.98	$144.55M	2.52	858,386 shs	464,301 shs
IBAC IB Acquisition	$11.26 -0.4%	$10.90	$10.19 ▼ $11.64	$56.59M	N/A	2,413 shs	3,249 shs
QSI Quantum-Si	$0.83 +6.3%	$0.77	$0.69 ▼ $3.10	$182.62M	3.25	1.42 million shs	2.57 million shs
QTRX Quanterix	$3.27 +2.8%	$3.08	$2.15 ▼ $8.77	$154.65M	1.04	870,156 shs	563,465 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDXS Codexis	0.00%	-2.94%	-20.48%	-44.77%	-46.77%
IBAC IB Acquisition	0.00%	-3.31%	+3.59%	+4.31%	+5.98%
QSI Quantum-Si	0.00%	+11.97%	+3.88%	-2.40%	-48.18%
QTRX Quanterix	0.00%	+6.51%	+23.86%	-24.31%	-38.30%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDXS Codexis	2.25	Hold	$6.50	392.42% Upside
IBAC IB Acquisition	1.00	Sell	N/A	N/A
QSI Quantum-Si	2.00	Hold	$1.00	19.86% Upside
QTRX Quanterix	1.67	Reduce	$3.00	-8.26% Downside

Current Analyst Ratings Breakdown

Latest IBAC, QSI, QTRX, and CDXS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/25/2026	CDXS Codexis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/24/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/9/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/2/2026	CDXS Codexis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/27/2026	IBAC IB Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/25/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	CDXS Codexis	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
8/17/2026	CDXS Codexis	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$9.00 ➝ $8.00
8/17/2026	QTRX Quanterix	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$4.00 ➝ $3.00
8/14/2026	IBAC IB Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
8/14/2026	QSI Quantum-Si	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 9/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDXS Codexis	$77.68M	1.86	N/A	N/A	$0.56 per share	2.36
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
QSI Quantum-Si	$1.61M	113.78	N/A	N/A	$1.02 per share	0.82
QTRX Quanterix	$138.90M	1.11	N/A	N/A	$6.33 per share	0.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDXS Codexis	-$43.97M	-$0.34	N/A	N/A	N/A	-39.55%	-74.36%	-23.58%	11/5/2026 (Estimated)
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
QSI Quantum-Si	-$101.34M	-$0.46	N/A	N/A	N/A	-6,138.26%	-47.12%	-43.18%	11/4/2026 (Estimated)
QTRX Quanterix	-$107.15M	-$2.63	N/A	N/A	N/A	-80.25%	-26.09%	-19.03%	11/9/2026 (Estimated)

Latest IBAC, QSI, QTRX, and CDXS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q3 2026	IBAC IB Acquisition	N/A	-$0.11	N/A	-$0.11	N/A	N/A
8/13/2026	Q2 2026	QSI Quantum-Si	-$0.1133	-$0.11	+$0.0033	-$0.11	$0.30 million	$0.34 million
8/11/2026	Q2 2026	CDXS Codexis	-$0.1417	-$0.13	+$0.0117	-$0.13	$13.82 million	$14.92 million
8/10/2026	Q2 2026	QTRX Quanterix	-$0.4103	-$1.04	-$0.6297	-$1.04	$37.48 million	$32.91 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDXS Codexis	N/A	N/A	N/A	N/A	N/A
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A
QSI Quantum-Si	N/A	N/A	N/A	N/A	N/A
QTRX Quanterix	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDXS Codexis	1.03	3.06	2.99
IBAC IB Acquisition	N/A	N/A	N/A
QSI Quantum-Si	N/A	9.97	9.80
QTRX Quanterix	N/A	3.40	2.45

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CDXS Codexis	78.54%
IBAC IB Acquisition	N/A
QSI Quantum-Si	39.90%
QTRX Quanterix	86.48%

Insider Ownership

Company	Insider Ownership
CDXS Codexis	3.50%
IBAC IB Acquisition	N/A
QSI Quantum-Si	22.04%
QTRX Quanterix	1.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CDXS Codexis	146	109.51 million	105.67 million	Optionable
IBAC IB Acquisition	2	5.01 million	N/A	N/A
QSI Quantum-Si	145	218.88 million	170.64 million	Optionable
QTRX Quanterix	450	47.29 million	46.58 million	Optionable

IBAC, QSI, QTRX, and CDXS Headlines

Recent News About These Companies

Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026

September 25 at 9:42 AM | markets.ft.com

Quanterix Corporation Launches PhenoCode 2.0 Molecular Barcoding Kit, Confirms TIME And High-Plex ADC Panels For Fourth Quarter Shipment, And Opens Custom ADC Panel Development

September 25 at 9:42 AM | marketscreener.comM

Analyzing Quanterix (NASDAQ:QTRX) & OmniAb (NASDAQ:OABI)

September 21, 2026 | americanbankingnews.com

Quanterix (NASDAQ:QTRX) Raised to "Hold" at Wall Street Zen

September 19, 2026 | americanbankingnews.com

Quanterix (NASDAQ:QTRX) Stock Rating Upgraded by Wall Street Zen

September 19, 2026 | marketbeat.com

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 16, 2026

September 17, 2026 | biospace.comB

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 16, 2026 | businesswire.com

Quanterix average analyst price target decreased by 18.18% to $3.06

September 15, 2026 | msn.com

Quanterix Names Yuri Fesko Chief Medical Officer

September 14, 2026 | rttnews.com

Quanterix Names Dr. Yuri Fesko Chief Medical Officer

September 14, 2026 | finance.yahoo.com

Quanterix Names Dr. Yuri Fesko Chief Medical Officer

September 14, 2026 | businesswire.com

3,635,411 Shares in Quanterix Corporation $QTRX Bought by BlackRock Inc.

September 4, 2026 | marketbeat.com

Quanterix (QTRX) Q2 2026 Earnings Call Transcript

August 17, 2026 | finance.yahoo.com

Quanterix Corporation

August 16, 2026 | edition.cnn.com

Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid ...

August 10, 2026 | finance.yahoo.com

Quanterix Names Jim Gute Chief Commercial Officer

August 10, 2026 | businesswire.com

Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12

August 6, 2026 | aol.comA

Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026

August 4, 2026 | lasvegassun.comL

Quanterix: Trading Below 1x Sales Despite A Changing Story

July 20, 2026 | seekingalpha.com

Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 16, 2026 | businesswire.com

Quanterix rises on coverage win for Alzheimer’s test

July 15, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBAC, QSI, QTRX, and CDXS Company Descriptions

Codexis NASDAQ:CDXS

$1.32 -0.05 (-3.65%)

As of 09/25/2026 04:00 PM Eastern

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

IB Acquisition NASDAQ:IBAC

$11.26 -0.05 (-0.40%)

As of 09/25/2026 02:56 PM Eastern

IB Acquisition Corp. is a blank check company. It formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. IB Acquisition Corp. is based in Boca Raton, Florida.

Quantum-Si NASDAQ:QSI

$0.83 +0.05 (+6.28%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$0.84 +0.00 (+0.56%)

As of 09/25/2026 07:59 PM Eastern

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

Quanterix NASDAQ:QTRX

$3.27 +0.09 (+2.83%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$3.16 -0.11 (-3.21%)

As of 09/25/2026 07:30 PM Eastern

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IBAC, QSI, QTRX, and CDXS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IBAC, QSI, QTRX, and CDXS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IBAC, QSI, QTRX, and CDXS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBAC, QSI, QTRX, and CDXS Company Descriptions

Codexis NASDAQ:CDXS

IB Acquisition NASDAQ:IBAC

Quantum-Si NASDAQ:QSI

Quanterix NASDAQ:QTRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IBAC, QSI, QTRX, and CDXS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IBAC, QSI, QTRX, and CDXS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IBAC, QSI, QTRX, and CDXS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBAC, QSI, QTRX, and CDXS Company Descriptions

Codexis NASDAQ:CDXS

IB Acquisition NASDAQ:IBAC

Quantum-Si NASDAQ:QSI

Quanterix NASDAQ:QTRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools